Principal Securities, Inc. Innoviva, Inc. Transaction History
Principal Securities, Inc.
- $3.63 Trillion
- Q2 2024
A detailed history of Principal Securities, Inc. transactions in Innoviva, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 978 shares of INVA stock, worth $18,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
978
Previous 576
69.79%
Holding current value
$18,650
Previous $8.78 Million
82.72%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding INVA
# of Institutions
222Shares Held
79.7MCall Options Held
20KPut Options Held
5.4K-
Black Rock Inc. New York, NY9.63MShares$184 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$139 Million20.14% of portfolio
-
Franklin Resources Inc San Mateo, CA6.62MShares$126 Million0.03% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$120 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$118 Million0.0% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.33B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...